Nervous System News and Research

Latest Nervous System News and Research

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.

23 Oct 2012

Intensive glycemic control does not reduce mortality in neurocritical care patients

A new study in BioMed Central's open access journal Critical Care suggests that intensive glycemic control does not reduce mortality in neurocritical care patients and could, in fact, lead to more neurological damage. Complicating the picture, poor glucose control also leads to worse recovery and should be avoided.

22 Oct 2012

Study reveals key chemical process that corrects potential visual errors in low-light conditions

On the road at night or on a tennis court at dusk, the eye can be deceived. Vision is not as sharp as in the light of day, and detecting a bicyclist on the road or a careening tennis ball can be tough.

20 Oct 2012

Shingles vaccine reduces risk of herpes zoster disease in older patients

Older adults who get the shingles vaccine have a nearly 50 percent reduced risk of developing the often debilitating disease, finds a new evidence review from The Cochrane Library.

20 Oct 2012

Sortilin receptor plays an important role in function of the immune system

To transport substances from the site of their production to their destination, the body needs a sophisticated transport and sorting system. Various receptors in and on the cells recognize certain molecules, pack them and ensure that they are transported to the right place. One of these receptors is Sortilin.

20 Oct 2012

Research director at Kessler Foundation awarded NIH grant to study effects of chemotherapy on brain

Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a grant by the National Institutes of Health to study the effects of chemotherapy on brain structure, neurophysiology, and psychomotor behavior.

20 Oct 2012

Study shows children with low levels of gene activity develop anxious dispositions

Decreased activity of a group of genes may explain why in young children the "fear center" of the anxious brain can't learn to distinguish real threats from the imaginary, according to a new University of Wisconsin study.

20 Oct 2012

Weill Cornell Medical College researcher wins 2012 William B. Coley Award

Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and provost for medical affairs of Cornell University, is a winner of the 2012 William B. Coley Award for Distinguished Research in Basic Immunology from the Cancer Research Institute for her outstanding achievements in immunology and cancer research.

19 Oct 2012

Longer looks: A Nobel for the economist behind the National Resident Matching Program; Helping Charlie end his life

A noted economist at Harvard, (Al) Roth was responsible for algorithms that matched medical students with their residency programs, children with their schools in Boston, and more recently, compatible kidney donors and transplant patients in paired donations.

19 Oct 2012

Study sheds light on how overeating can lead to obesity and diabetes

New research from Mount Sinai School of Medicine sheds light on how overeating can cause a malfunction in brain insulin signaling, and lead to obesity and diabetes. Christoph Buettner, MD, PhD, Associate Professor of Medicine (Endocrinology, Diabetes and Bone Disease) and his research team found that overeating impairs the ability of brain insulin to suppress the breakdown of fat in adipose tissue.

19 Oct 2012

Antidepressant use may increase risk of strokes caused by bleeding in the brain

Research shows that use of popular antidepressants is linked to an increased risk of some strokes caused by bleeding in the brain, but that the risk is low, according to a multi-study analysis published in the October 17, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Oct 2012

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Neuralstem, Inc. announced that it has begun dosing the second cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).

19 Oct 2012

New research sheds light on consequence of overeating

New research from Mount Sinai School of Medicine sheds light on how overeating can cause a malfunction in brain insulin signaling, and lead to obesity and diabetes.

18 Oct 2012

BioLineRx completes pre-clinical development of BL-8020 for HCV

BioLineRx, a biopharmaceutical development company, announced today that it has successfully completed the pre-clinical development of BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus (HCV), and plans to commence a Phase I/II safety and efficacy study for BL-8020 in Europe during the first quarter of 2013.

17 Oct 2012

Companionship can reduce nerve-related pain

Companionship has the potential to reduce pain linked to nerve damage, according to a new study.

16 Oct 2012

Animal research shows promise in treating AD, brain damage and heart problems resulting from SCIs

New animal studies provide additional support for investigating stem cell treatments for Parkinson's disease, head trauma, and dangerous heart problems that accompany spinal cord injury, according to research findings released today.

16 Oct 2012

NIAID-funded study to evaluate PPSV23 and PCV13 in Phase Iib pneumococcal trial

Researchers plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier generation vaccine against pneumonia and other pneumococcal diseases.

16 Oct 2012

Study demonstrates how new scientific knowledge drives novel treatments for spinal cord injuries

Research released today demonstrates how new scientific knowledge is driving innovative treatments for spinal cord injuries. Spinal cord damage is debilitating and life-altering, limiting or preventing movement and feeling for millions worldwide, and leading to chronic health conditions and pain.

16 Oct 2012

Civitas to present CVT-301 Phase 1 study results at Parkinson's Disease Therapeutics Conference

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.

15 Oct 2012

DNA method leads to more effective treatment of neuroblastoma in children

After leukaemia and brain tumours, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for all cases of neuroblastoma in Sweden, and which has led to more effective treatment at individual level.

15 Oct 2012

Nervous System News and Research

Latest Nervous System News and Research

Pfizer announces intention to acquire NextWave

Intensive glycemic control does not reduce mortality in neurocritical care patients

Study reveals key chemical process that corrects potential visual errors in low-light conditions

Shingles vaccine reduces risk of herpes zoster disease in older patients

Sortilin receptor plays an important role in function of the immune system

Research director at Kessler Foundation awarded NIH grant to study effects of chemotherapy on brain

Study shows children with low levels of gene activity develop anxious dispositions

Weill Cornell Medical College researcher wins 2012 William B. Coley Award

Longer looks: A Nobel for the economist behind the National Resident Matching Program; Helping Charlie end his life

Study sheds light on how overeating can lead to obesity and diabetes

Antidepressant use may increase risk of strokes caused by bleeding in the brain

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

New research sheds light on consequence of overeating

BioLineRx completes pre-clinical development of BL-8020 for HCV

Companionship can reduce nerve-related pain

Animal research shows promise in treating AD, brain damage and heart problems resulting from SCIs

NIAID-funded study to evaluate PPSV23 and PCV13 in Phase Iib pneumococcal trial

Study demonstrates how new scientific knowledge drives novel treatments for spinal cord injuries

Civitas to present CVT-301 Phase 1 study results at Parkinson's Disease Therapeutics Conference

DNA method leads to more effective treatment of neuroblastoma in children

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Nervous System News and Research

Latest Nervous System News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in